These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 17403983)
1. Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. Asherson P; Brookes K; Franke B; Chen W; Gill M; Ebstein RP; Buitelaar J; Banaschewski T; Sonuga-Barke E; Eisenberg J; Manor I; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant J; Steinhausen HC; Faraone SV Am J Psychiatry; 2007 Apr; 164(4):674-7. PubMed ID: 17403983 [TBL] [Abstract][Full Text] [Related]
2. Association between the dopamine transporter gene and the inattentive subtype of attention deficit hyperactivity disorder in Taiwan. Shang CY; Gau SS; Liu CM; Hwu HG Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):421-8. PubMed ID: 20800641 [TBL] [Abstract][Full Text] [Related]
3. Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder. Mazei-Robison MS; Couch RS; Shelton RC; Stein MA; Blakely RD Neuropharmacology; 2005 Nov; 49(6):724-36. PubMed ID: 16171832 [TBL] [Abstract][Full Text] [Related]
4. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample. Laucht M; Skowronek MH; Becker K; Schmidt MH; Esser G; Schulze TG; Rietschel M Arch Gen Psychiatry; 2007 May; 64(5):585-90. PubMed ID: 17485610 [TBL] [Abstract][Full Text] [Related]
5. The dopamine transporter haplotype and reward-related striatal responses in adult ADHD. Hoogman M; Onnink M; Cools R; Aarts E; Kan C; Arias Vasquez A; Buitelaar J; Franke B Eur Neuropsychopharmacol; 2013 Jun; 23(6):469-78. PubMed ID: 22749356 [TBL] [Abstract][Full Text] [Related]
6. Sequence variation in the 3'-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD). Feng Y; Wigg KG; Makkar R; Ickowicz A; Pathare T; Tannock R; Roberts W; Malone M; Kennedy JL; Schachar R; Barr CL Am J Med Genet B Neuropsychiatr Genet; 2005 Nov; 139B(1):1-6. PubMed ID: 16082693 [TBL] [Abstract][Full Text] [Related]
7. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder. Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704 [TBL] [Abstract][Full Text] [Related]
8. A common haplotype at the dopamine transporter gene 5' region is associated with attention-deficit/hyperactivity disorder. Genro JP; Polanczyk GV; Zeni C; Oliveira AS; Roman T; Rohde LA; Hutz MH Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1568-75. PubMed ID: 18802919 [TBL] [Abstract][Full Text] [Related]
9. Genetics of preparation and response control in ADHD: the role of DRD4 and DAT1. Albrecht B; Brandeis D; Uebel-von Sandersleben H; Valko L; Heinrich H; Xu X; Drechsler R; Heise A; Kuntsi J; Müller UC; Asherson P; Steinhausen HC; Rothenberger A; Banaschewski T J Child Psychol Psychiatry; 2014 Aug; 55(8):914-23. PubMed ID: 24521003 [TBL] [Abstract][Full Text] [Related]
10. Intelligence in DSM-IV combined type attention-deficit/hyperactivity disorder is not predicted by either dopamine receptor/transporter genes or other previously identified risk alleles for attention-deficit/hyperactivity disorder. Sonuga-Barke EJ; Brookes KJ; Buitelaar J; Anney R; Bitsakou P; Baeyens D; Buschgens C; Chen W; Christiansen H; Eisenberg J; Kuntsi J; Manor I; Meliá A; Mulligan A; Rommelse N; Müller UC; Uebel H; Banaschewski T; Ebstein R; Franke B; Gill M; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant J; Steinhausen HC; Thompson M; Taylor E; Asherson P; Faraone SV Am J Med Genet B Neuropsychiatr Genet; 2008 Apr; 147(3):316-9. PubMed ID: 18023044 [TBL] [Abstract][Full Text] [Related]
11. Association of ADHD with genetic variants in the 5'-region of the dopamine transporter gene: evidence for allelic heterogeneity. Brookes KJ; Xu X; Anney R; Franke B; Zhou K; Chen W; Banaschewski T; Buitelaar J; Ebstein R; Eisenberg J; Gill M; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant J; Sonuga-Barke E; Steinhausen HC; Taylor E; Faraone SV; Asherson P Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1519-23. PubMed ID: 18668530 [TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD. Kambeitz J; Romanos M; Ettinger U Pharmacogenomics J; 2014 Feb; 14(1):77-84. PubMed ID: 23588108 [TBL] [Abstract][Full Text] [Related]
13. A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Brookes KJ; Mill J; Guindalini C; Curran S; Xu X; Knight J; Chen CK; Huang YS; Sethna V; Taylor E; Chen W; Breen G; Asherson P Arch Gen Psychiatry; 2006 Jan; 63(1):74-81. PubMed ID: 16389200 [TBL] [Abstract][Full Text] [Related]
14. The VNTR polymorphism in the human dopamine transporter gene: improved detection and absence of association of VNTR alleles with attention-deficit hyperactivity disorder. Simsek M; Al-Sharbati M; Al-Adawi S; Lawatia K Genet Test; 2006; 10(1):31-4. PubMed ID: 16545000 [TBL] [Abstract][Full Text] [Related]
15. Replication of an association of a promoter polymorphism of the dopamine transporter gene and Attention Deficit Hyperactivity Disorder. Doyle C; Brookes K; Simpson J; Park J; Scott S; Coghill DR; Hawi Z; Kirley A; Gill M; Kent L Neurosci Lett; 2009 Sep; 462(2):179-81. PubMed ID: 19576958 [TBL] [Abstract][Full Text] [Related]
16. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5. Kustanovich V; Ishii J; Crawford L; Yang M; McGough JJ; McCracken JT; Smalley SL; Nelson SF Mol Psychiatry; 2004 Jul; 9(7):711-7. PubMed ID: 14699430 [TBL] [Abstract][Full Text] [Related]
17. Association between the dopamine transporter gene (DAT1) and attention deficit hyperactivity disorder-related traits in healthy adults. Jeong SH; Choi KS; Lee KY; Kim EJ; Kim YS; Joo EJ Psychiatr Genet; 2015 Jun; 25(3):119-26. PubMed ID: 25915480 [TBL] [Abstract][Full Text] [Related]
18. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder. Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773 [TBL] [Abstract][Full Text] [Related]
19. Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD. Bellgrove MA; Barry E; Johnson KA; Cox M; Dáibhis A; Daly M; Hawi Z; Lambert D; Fitzgerald M; McNicholas F; Robertson IH; Gill M; Kirley A Neuropsychopharmacology; 2008 Sep; 33(10):2536-45. PubMed ID: 18046306 [TBL] [Abstract][Full Text] [Related]